These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1688504

  • 1. In vitro differentiation of leukemic cells to eosinophils in the presence of interleukin-5 in two cases of acute myeloid leukemia with the translocation (8;21)(q22;q22).
    Ema H, Kitano K, Suda T, Sato Y, Muroi K, Ohta M, Yoshida M, Sakamoto S, Eguchi M, Miura Y.
    Blood; 1990 Jan 15; 75(2):350-6. PubMed ID: 1688504
    [Abstract] [Full Text] [Related]

  • 2. In vivo control of differentiation of myeloid leukemic cells by recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3.
    Lotem J, Sachs L.
    Blood; 1988 Feb 15; 71(2):375-82. PubMed ID: 2447982
    [Abstract] [Full Text] [Related]

  • 3. Hematopoietic cytokine-dependent differentiation to eosinophils and neutrophils in a newly established acute promyelocytic leukemia cell line with t(15;17).
    Kishi K, Toba K, Azegami T, Tsukada N, Uesugi Y, Masuko M, Niwano H, Hashimoto S, Sakaue M, Furukawa T, Koike T, Takahashi H, Maekawa T, Abe T, Aizawa Y.
    Exp Hematol; 1998 Feb 15; 26(2):135-42. PubMed ID: 9472803
    [Abstract] [Full Text] [Related]

  • 4. Target cells for granulocyte colony-stimulating factor, interleukin-3, and interleukin-5 in differentiation pathways of neutrophils and eosinophils.
    Ema H, Suda T, Nagayoshi K, Miura Y, Civin CI, Nakauchi H.
    Blood; 1990 Nov 15; 76(10):1956-61. PubMed ID: 1700728
    [Abstract] [Full Text] [Related]

  • 5. Cooperative effects of interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor: a new myeloid cell line inducible to eosinophils.
    Paul CC, Tolbert M, Mahrer S, Singh A, Grace MJ, Baumann MA.
    Blood; 1993 Mar 01; 81(5):1193-9. PubMed ID: 8443379
    [Abstract] [Full Text] [Related]

  • 6. Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-5.
    Sonoda Y, Arai N, Ogawa M.
    Leukemia; 1989 Jan 01; 3(1):14-8. PubMed ID: 2642572
    [Abstract] [Full Text] [Related]

  • 7. Growth of clonogenic myeloblastic leukemic cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factors.
    Asano Y, Okamura S, Shibuya T, Harada M, Niho Y.
    Blood; 1988 Nov 01; 72(5):1682-6. PubMed ID: 2460160
    [Abstract] [Full Text] [Related]

  • 8. Differentiation and functional activity of human eosinophilic cells from an eosinophil HL-60 subline: response to recombinant hematopoietic growth factors.
    Fabian I, Lass M, Kletter Y, Golde DW.
    Blood; 1992 Aug 01; 80(3):788-94. PubMed ID: 1379088
    [Abstract] [Full Text] [Related]

  • 9. Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5.
    Touw I, Donath J, Pouwels K, van Buitenen C, Schipper P, Santini V, Hagemeijer A, Löwenberg B, Delwel R.
    Leukemia; 1991 Aug 01; 5(8):687-92. PubMed ID: 1715959
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
    Delwel R, van Buitenen C, Salem M, Oosterom R, Touw I, Löwenberg B.
    Leukemia; 1990 Aug 01; 4(8):557-60. PubMed ID: 2201834
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD.
    Leukemia; 1991 May 01; 5(5):386-91. PubMed ID: 1709711
    [Abstract] [Full Text] [Related]

  • 17. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF.
    Clutterbuck EJ, Hirst EM, Sanderson CJ.
    Blood; 1989 May 01; 73(6):1504-12. PubMed ID: 2653458
    [Abstract] [Full Text] [Related]

  • 18. The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture.
    Miyauchi J, Kelleher CA, Wong GG, Yang YC, Clark SC, Minkin S, Minden MD, McCulloch EA.
    Leukemia; 1988 Jun 01; 2(6):382-7. PubMed ID: 2453760
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-6 reduces the optimal growth in vitro of leukemic blast progenitors from acute myeloblastic leukemia patients.
    Suzuki T, Bessho M, Hirashma K, Tohda S, Nagata K, Imai Y, Nara N.
    Acta Haematol; 1992 Jun 01; 87(1-2):63-8. PubMed ID: 1374992
    [Abstract] [Full Text] [Related]

  • 20. Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture.
    Coutinho LH, Will A, Radford J, Schiró R, Testa NG, Dexter TM.
    Blood; 1990 Jun 01; 75(11):2118-29. PubMed ID: 1693295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.